Evidence map›Paper›PMID 37356087›Full record

ArticleOphthalmology and therapy2023

Qualitative Exploration of the Visual Function Impairments and Health-Related Quality of Life Impacts of Amblyopia in Adult and Pediatric Populations.

Sharan Randhawa, Natasha Griffiths, Paul O'Brien, Charlotte Panter, Kieran Boparai, Richard Harrad, Nausheen Khuddus, Ann Webber, Christine Bouchet, Federico Felizzi

Open access · goldAbstract read
In one paragraph

Article in Ophthalmology and therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 4 countries.

Sharan RandhawaAdelphi Values Ltd, Bollington, Cheshire, UK. sharan.randhawa@adelphivalues.com.ORCID http://orcid.org/0000-0003-0224-8061
Natasha GriffithsAdelphi Values Ltd, Bollington, Cheshire, UK.ORCID http://orcid.org/0000-0001-9228-1847
Paul O'BrienNovartis Ireland Ltd, Dublin, Ireland.ORCID http://orcid.org/0000-0002-6064-8023
Charlotte PanterAdelphi Values Ltd, Bollington, Cheshire, UK.ORCID http://orcid.org/0000-0001-7172-8937
Kieran BoparaiAdelphi Values Ltd, Bollington, Cheshire, UK.
Richard HarradBristol Eye Hospital, Bristol, UK.
Nausheen KhuddusFamily Focus Eye Care, NKB Services, Gainesville, FL, USA.
Ann WebberSchool of Optometry and Vision Science, Queensland University of Technology, Brisbane, Australia.ORCID http://orcid.org/0000-0003-3935-3615
Christine BouchetNovartis Pharma AG, Basel, Switzerland.ORCID http://orcid.org/0000-0002-9737-1179
Federico FelizziNovartis Pharma AG, Basel, Switzerland.
Adelphi Group (United Kingdom) · GBNovartis (Switzerland) · CHBristol Eye Hospital · GBNovartis (Ireland) · IEQueensland University of Technology · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAmblyopia is a reduction in vision in one or both eyes due to impaired development of the visual pathway. This study explored the experience of amblyopia and treatment from the patient, caregiver, and clinician perspectives.

methodsA targeted literature review, including a review of social media listening (SML) studies, was conducted. Next, qualitative interviews were conducted with amblyopia patients, caregivers of children with amblyopia, and ophthalmologists with experience treating patients with amblyopia. The findings informed the development of a disease model. Amblyopia clinical experts provided input at key stages.

resultsTwelve data sources were reviewed, including qualitative studies in the literature and SML studies. Overall, 133 patients/caregivers were interviewed (23 adults, 16 adolescents, 47 child-caregiver dyads), plus 10 ophthalmologists from the United States, France, and Germany. Reduced visual acuity, impaired depth perception, impaired peripheral vision, and double vision were the most frequently reported symptoms. Amblyopia impacted daily activities (reading, using digital devices), the ability to move around, school/work (productivity, seeing the board in class), emotional well-being (frustration, sadness), and social functioning (difficulty socializing). Treatments, including patching and corrective lens, also impacted daily activities (using digital devices, sports/leisure), mobility (bumping into things), and work/school (tasks taking longer) as well as emotional well-being (embarrassment), and social functioning (bullying/stigma).

conclusionThe findings contribute valuable insights into the adult and pediatric experience of amblyopia from a multi-stakeholder perspective. The findings were used to critically assess existing clinical outcome assessments and supported the development of patient- and observer-reported outcome measures for use in amblyopia clinical trials.

Indexed as

AmblyopiaOphthalmologyQualitative researchQuality of life

Identifiers

PMID37356087
PMCPMC10441976
OpenAlexW4381951049

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.